Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As people acclimatize to the new normal, it’s time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections. Once infected wi...
Co-Diagnostics, Inc. to Sponsor, Present, and Host Booth at 66th Annual CARPHA Conference on Sept 15-17 in Jamaica PR Newswire SALT LAKE CITY , Sept. 14, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecul...
New York, New York--(Newsfile Corp. - September 13, 2022) - Levi & Korsinsky, LLP notifies investors in Co-Diagnostics, Inc. ("Co-Dx" or the "Company") (NASDAQ: CODX) of a class action securities lawsuit. The lawsuit on behalf of Co-Dx investors has been commenced in the the United Stat...
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 PR Newswire SALT LAKE CITY , Sept. 12, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"),...
Summary We reiterate the hold thesis on Co-Diagnostics following Q2 FY22 earnings. Covid-19 turnover continues to diminish for CODX whilst surging for rival test providers. Inventory levels for the company spiked year over year as the Omicron-led demand in testing faded. W...
Co-Diagnostics, Inc. to Host Booth at Medical Fair Asia 2022 in Singapore on Aug 31-Sep 2 PR Newswire SALT LAKE CITY , Aug. 31, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or Co-Dx), a molecular diagnostics company wit...
Co-Diagnostics, Inc. to Present at 14th Next Generation Dx Summit in Washington, D.C. PR Newswire SALT LAKE CITY , Aug. 22, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, pat...
NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. (“Co-Diagnostics”) (NASDAQ: CODX) in the United States District Court for the Southern District of New York on behalf of ...
An analyst price target cut was the impetus behind Co-Diagnostics ' (NASDAQ: CODX) share price drop on Monday. The biotech's stock lost nearly 4% of its value that day; what didn't help was that the cut was preceded by a recommendation downgrade from a different prognosticator. ...
Gainers: Terns Pharmaceuticals ( TERN ) +36% . Rani Therapeutics ( RANI ) +25% . AirSculpt Technologies ( AIRS ) +21% . Larimar Therapeutics ( LRMR ) +21% . Neptune Wellness ( NEPT ) +18% . Losers: PLx Pharma ( PLXP ...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 PR Newswire SALT LAKE CITY , June 18, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented plat...